![](/img/cover-not-exists.png)
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance
Raaijmakers, Marieke I.G., Widmer, Daniel S., Narechania, Apurva, Eichhoff, Ossia, Freiberger, Sandra N., Wenzina, Judith, Cheng, Phil F., Mihic-Probst, Daniela, Desalle, Rob, Dummer, Reinhard, LevesqVolume:
7
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.12848
Date:
November, 2016
File:
PDF, 2.79 MB
english, 2016